Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Authors
Keywords
Sporadic Parkinson’s disease, Mitochondria, Biomarkers, LRRK2, Fibroblasts, Parkin
Journal
MOLECULAR NEUROBIOLOGY
Volume 53, Issue 8, Pages 5161-5177
Publisher
Springer Nature
Online
2015-09-23
DOI
10.1007/s12035-015-9435-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in actin dynamics and F-actin structure both in synaptoneurosomes of LRRK2(R1441G) mutant mice and in primary human fibroblasts of LRRK2(G2019S) mutation carriers
- (2015) M. Caesar et al. NEUROSCIENCE
- Mitochondrial impairment observed in fibroblasts from South African Parkinson’s disease patients with parkin mutations
- (2014) Celia van der Merwe et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effect of resveratrol on mitochondrial function: Implications in parkin-associated familiar Parkinson's disease
- (2014) Anna Ferretta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease
- (2014) Giulia Ambrosi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor
- (2014) Jaclyn L. Henderson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Loss of Mitochondrial Fission Depletes Axonal Mitochondria in Midbrain Dopamine Neurons
- (2014) A. Berthet et al. JOURNAL OF NEUROSCIENCE
- The Impact of Mitochondrial Fusion and Fission Modulation in Sporadic Parkinson’s Disease
- (2014) Daniel Santos et al. MOLECULAR NEUROBIOLOGY
- LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity
- (2014) Loukia Parisiadou et al. NATURE NEUROSCIENCE
- Early-onset Parkinson's disease due to PINK1 p.Q456X mutation – Clinical and functional study
- (2014) Joanna Siuda et al. PARKINSONISM & RELATED DISORDERS
- Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
- (2014) A. Beilina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- G2019S LRRK2 mutant fibroblasts from Parkinson’s disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy
- (2014) Sokhna M.S. Yakhine-Diop et al. TOXICOLOGY
- Parkin and PINK1: much more than mitophagy
- (2014) Leslie A. Scarffe et al. TRENDS IN NEUROSCIENCES
- Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo
- (2014) Phillip M. Rappold et al. Nature Communications
- Long-Term Health of Dopaminergic Neuron Transplants in Parkinson's Disease Patients
- (2014) Penelope J. Hallett et al. Cell Reports
- LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex
- (2014) Maria D. Cirnaru et al. Frontiers in Molecular Neuroscience
- Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism
- (2014) Jean-Marc Taymans et al. Frontiers in Genetics
- Does Uncoupling Protein 2 Expression Qualify as Marker of Disease Status in LRRK2-Associated Parkinson's Disease?
- (2013) Anne Grünewald et al. ANTIOXIDANTS & REDOX SIGNALING
- ERKed by LRRK2: A cell biological perspective on hereditary and sporadic Parkinson's disease
- (2013) Manish Verma et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Inhibition of LRRK2 kinase activity stimulates macroautophagy
- (2013) Claudia Manzoni et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson’s disease
- (2013) Heather Mortiboys et al. BRAIN
- The role of inflammation in sporadic and familial Parkinson’s disease
- (2013) Michela Deleidi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation
- (2013) Yu-Chin Su et al. HUMAN MOLECULAR GENETICS
- Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily
- (2013) Klodjan Stafa et al. HUMAN MOLECULAR GENETICS
- Lysosomal impairment in Parkinson's disease
- (2013) Benjamin Dehay et al. MOVEMENT DISORDERS
- Leucine-rich repeat kinase 2 functionally interacts with microtubules and kinase-dependently modulates cell migration
- (2013) Mareike Caesar et al. NEUROBIOLOGY OF DISEASE
- Mitochondrial dysfunction and oxidative stress in Parkinson's disease
- (2013) Sudhakar Raja Subramaniam et al. PROGRESS IN NEUROBIOLOGY
- Mutant LRRK2 Elicits Calcium Imbalance and Depletion of Dendritic Mitochondria in Neurons
- (2012) Salvatore J. Cherra et al. AMERICAN JOURNAL OF PATHOLOGY
- The search for genetic mouse models of prodromal Parkinson's disease
- (2012) Gaynor A. Smith et al. EXPERIMENTAL NEUROLOGY
- G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization
- (2012) Tatiana D. Papkovskaia et al. HUMAN MOLECULAR GENETICS
- LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1
- (2012) X. Wang et al. HUMAN MOLECULAR GENETICS
- Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity
- (2012) C. Yao et al. HUMAN MOLECULAR GENETICS
- Phosphatase and Tensin Homolog (PTEN)-induced Putative Kinase 1 (PINK1)-dependent Ubiquitination of Endogenous Parkin Attenuates Mitophagy
- (2012) Aleksandar Rakovic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein
- (2012) Jingwen Niu et al. JOURNAL OF NEUROCHEMISTRY
- Primary Skin Fibroblasts as a Model of Parkinson's Disease
- (2012) Georg Auburger et al. MOLECULAR NEUROBIOLOGY
- Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
- (2012) David N. Hauser et al. NEUROBIOLOGY OF DISEASE
- Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson's Disease
- (2012) O. Cooper et al. Science Translational Medicine
- Mitochondrial Quality Control and Dynamics in Parkinson's Disease
- (2011) Melissa K. McCoy et al. ANTIOXIDANTS & REDOX SIGNALING
- Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson’s disease mutations and LRRK2 pharmacological inhibition
- (2011) Elizabeth A. Doggett et al. JOURNAL OF NEUROCHEMISTRY
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients
- (2010) A. Rakovic et al. HUMAN MOLECULAR GENETICS
- Mutant Parkin Impairs Mitochondrial Function and Morphology in Human Fibroblasts
- (2010) Anne Grünewald et al. PLoS One
- Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila
- (2009) C.-H. Ng et al. JOURNAL OF NEUROSCIENCE
- PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
- (2009) C. Vives-Bauza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial function and morphology are impaired inparkin-mutant fibroblasts
- (2008) Heather Mortiboys et al. ANNALS OF NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now